SVA Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-10,266
Closed -$2.1M 234
2018
Q1
$2.1M Buy
+10,266
New +$1.72M 0.26% 88
2017
Q4
Sell
-10,266
Closed -$2.1M 210
2017
Q3
$2.1M Sell
10,266
-670
-6% -$156K 0.26% 88
2017
Q2
$2.66M Buy
10,936
+580
+6% +$136K 0.34% 76
2017
Q1
$2.47M Sell
10,356
-1,921
-16% -$447K 0.34% 77
2016
Q4
$2.58M Sell
12,277
-10,896
-47% -$2.26M 0.38% 74
2016
Q3
$5.34M Sell
23,173
-2,633
-10% -$643K 0.83% 39
2016
Q2
$5.96M Buy
25,806
+1,656
+7% +$382K 0.96% 28
2016
Q1
$6.47M Buy
24,150
+2,008
+9% +$575K 1.07% 26
2015
Q4
$6.92M Buy
22,142
+7,407
+50% +$2.21M 1.2% 22
2015
Q3
$4M Buy
14,735
+1,066
+8% +$327K 0.75% 45
2015
Q2
$4.15M Buy
13,669
+1,332
+11% +$397K 0.76% 46
2015
Q1
$3.67M Buy
+12,337
New +$3.52M 0.67% 55

Other funds holding AGN

SVA Wealth Management's AGN Position: Q2 2018 in Review

SVA Wealth Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 10,266 shares — an estimated $2.1M sold.

SVA Wealth Management first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $6.92M in Q4 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • SVA Wealth Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • SVA Wealth Management sold 10,266 Allergan plc shares in Q2 2018, an estimated $2.1M.
  • SVA Wealth Management first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • SVA Wealth Management's Allergan plc position peaked at $6.92M in Q4 2015.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on SVA Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.